Market Overview:
The global ovarian cysts market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of ovarian cysts, increasing awareness about ovarian cysts, and technological advancements in the field of diagnosis and treatment of ovarian cysts. However, the high cost associated with diagnosis and treatment is expected to restrain the growth of this market during the forecast period. Based on type, functional ovary cyst accounted for majority share in 2017 and is projected to maintain its dominance during the forecast period. This can be attributed to higher incidence rate as compared non-functional ovary cyst.
Product Definition:
An ovarian cyst is a fluid-filled sac that develops on or inside an ovary. Most ovarian cysts are harmless and go away without treatment. However, some may cause symptoms such as pain, bloating, or irregular periods. Rarely, an ovarian cyst may be cancerous.
Functional Cysts:
Functional cysts are benign lesions that produce no symptoms and can be found in any part of the body. Functional cysts may occur as a result of genetic disorders or due to drug & chemical exposure.
Non-Functional Cysts:
Non-functional cysts are those that do not develop into an ovary and have a thin wall. These can be found in the ovaries of women between the age group of 20 to 50 years. They are painless and remain asymptomatic till discovery, which is usually during a routine ultrasound scan for fertility purposes.
Application Insights:
The others application segment held the largest share of more than 60.0% in 2017. The other applications include research settings and home care management. Increasing awareness about ovulation induction therapies for assisted reproductive technology procedures is expected to drive the market growth over the forecast period, especially in developed regions like North America and Europe.
Functional ovarian cysts are majorly found in women above 40 years of age who have had children previously or are currently pregnant or trying to get pregnant, as these functional ovarian cysts cause no harm to women's health but they may lead to complications during pregnancy if not treated timely by a doctor.
On basis of size, this market is segmented into small (less than 10cm), medium (10-19 cm),.
Regional Analysis:
North America dominated the global ovarian cysts market in 2017. The presence of well-established healthcare facilities and high awareness levels pertaining to early diagnosis are some factors attributing toward the largest share of this region. In addition, increasing incidence rates of malignant tumors in women are also contributing toward growth. For instance, according to statistics published by American Cancer Society in 2018, around 1 million new cases were estimated to be diagnosed in U.S., with about 80% occurring among women.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to improving healthcare infrastructure and rising patient awareness regarding early diagnosis methods for various diseases including ovarian cysts.
Growth Factors:
- Increasing incidence of ovarian cysts
- Rising awareness about ovarian cysts and their symptoms
- Growing demand for minimally invasive treatments for ovarian cysts
- Technological advancements in the diagnosis and treatment of ovarian cysts
- increasing prevalence of obesity and other risk factors that contribute to the development of ovarian cysts
Scope Of The Report
Report Attributes
Report Details
Report Title
Ovarian Cysts Market Research Report
By Type
Functional Cysts, Non-Functional Cysts
By Application
Hospital, Clinic, Others
By Companies
Pfizer, Teva Pharmaceutical Industries, Quest Diagnostics, Novartis, General Electric, Merck, Boston Scientific, Medtronic
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
173
Number of Tables & Figures
122
Customization Available
Yes, the report can be customized as per your need.
Global Ovarian Cysts Market Report Segments:
The global Ovarian Cysts market is segmented on the basis of:
Types
Functional Cysts, Non-Functional Cysts
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Teva Pharmaceutical Industries
- Quest Diagnostics
- Novartis
- General Electric
- Merck
- Boston Scientific
- Medtronic
Highlights of The Ovarian Cysts Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Functional Cysts
- Non-Functional Cysts
- By Application:
- Hospital
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ovarian Cysts Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ovarian cysts are fluid-filled sacs that can form on the ovaries. They are most commonly found in women between the ages of 25 and 45, but they can also occur at any age. Ovarian cysts may cause mild to severe pain, irregular menstrual periods, and infertility.
Some of the major players in the ovarian cysts market are Pfizer, Teva Pharmaceutical Industries, Quest Diagnostics, Novartis, General Electric, Merck, Boston Scientific, Medtronic.
The ovarian cysts market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Ovarian Cysts Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Ovarian Cysts Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Ovarian Cysts Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Ovarian Cysts Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Ovarian Cysts Market Size & Forecast, 2018-2028
4.5.1 Ovarian Cysts Market Size and Y-o-Y Growth
4.5.2 Ovarian Cysts Market Absolute $ Opportunity
Chapter 5 Global Ovarian Cysts Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Ovarian Cysts Market Size Forecast by Type
5.2.1 Functional Cysts
5.2.2 Non-Functional Cysts
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Ovarian Cysts Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Ovarian Cysts Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Ovarian Cysts Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Ovarian Cysts Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Ovarian Cysts Analysis and Forecast
9.1 Introduction
9.2 North America Ovarian Cysts Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Ovarian Cysts Market Size Forecast by Type
9.6.1 Functional Cysts
9.6.2 Non-Functional Cysts
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Ovarian Cysts Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Ovarian Cysts Analysis and Forecast
10.1 Introduction
10.2 Europe Ovarian Cysts Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Ovarian Cysts Market Size Forecast by Type
10.6.1 Functional Cysts
10.6.2 Non-Functional Cysts
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Ovarian Cysts Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Ovarian Cysts Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Ovarian Cysts Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Ovarian Cysts Market Size Forecast by Type
11.6.1 Functional Cysts
11.6.2 Non-Functional Cysts
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Ovarian Cysts Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Ovarian Cysts Analysis and Forecast
12.1 Introduction
12.2 Latin America Ovarian Cysts Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Ovarian Cysts Market Size Forecast by Type
12.6.1 Functional Cysts
12.6.2 Non-Functional Cysts
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Ovarian Cysts Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Ovarian Cysts Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Ovarian Cysts Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Ovarian Cysts Market Size Forecast by Type
13.6.1 Functional Cysts
13.6.2 Non-Functional Cysts
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Ovarian Cysts Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Ovarian Cysts Market: Competitive Dashboard
14.2 Global Ovarian Cysts Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Teva Pharmaceutical Industries
14.3.3 Quest Diagnostics
14.3.4 Novartis
14.3.5 General Electric
14.3.6 Merck
14.3.7 Boston Scientific
14.3.8 Medtronic
